Thomas Müller

Interleukin-1β and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients

Doris Blum-Degena, Thomas Müller, W. Kuhn et al. · Neuroscience Letters · 1995 · 792 citations

Immunology, Neurochemical Biomarkers, Neuroinflammation +16

Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease

Karsten M. Strauss, L. Miguel Martins, Hélène Plun‐Favreau et al. · Human Molecular Genetics · 2005 · 563 citations · Full text

Mitophagy, Mitochondrial Dysfunction, Genetics +16

Sarizotan as a treatment for dyskinesias in Parkinson's disease: A double‐blind placebo‐controlled trial

Christopher G. Goetz, Philippe Damier, Christine Hicking et al. · Movement Disorders · 2006 · 252 citations

Coenzyme Q10 supplementation provides mild symptomatic benefit in patients with Parkinson's disease

Thomas Müller, Thomas Büttner, Ali-Farshad Gholipour et al. · Neuroscience Letters · 2003 · 201 citations

Medicine, Parkinson Disease, Mild Symptomatic Benefit +4

Clinical score for nonbacterial osteitis in children and adults

Annette Jansson, Thomas Müller, Leonhard Gliera et al. · Arthritis & Rheumatism · 2009 · 195 citations